Gynaecological Cancers
3 clinical trials · Condition
◉ Watch Gynaecological Cancers
| Record | Firm | Date |
|---|---|---|
| ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss (NCT04065269) | Institute of Cancer Research, United Kingdom | 2019-11-27 |
Track Gynaecological Cancers automatically
Every clearance here is in the API, with alerts when new ones post.